RxDoctor Payments Data

Wayne Justice, MD

Family Medicine · Niceville, FLNPI 1487624201

Payments from drug & device makers

$11,259in general payments, 2019–2025

Across 669 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Astellas Pharma US Inc$923
  • Jazz Pharmaceuticals Inc.$809
  • Novo Nordisk$758
  • Amgen$662
  • plus $6K from 42 others

What the payments were for

  • Food & beverage$10,88997%
  • Education$3713%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,259 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$99,435
Medicare patients
161
Services billed
2,047

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide47$48,545
TrulicityDulaglutide26$23,335
JardianceEmpagliflozin16$14,395
EliquisApixaban22$13,158
FarxigaDapagliflozin Propanediol16$12,170
MyrbetriqMirabegron19$11,798
Humulin R U-500 KwikpenInsulin Regular, Human11$11,263
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,039
XareltoRivaroxaban16$8,576
TradjentaLinagliptin13$6,870
Repatha SureclickEvolocumab12$6,269
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen80$2,980
Colesevelam Hcl12$2,779
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,657
Buprenorphine18$1,225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,028$71,88073 claims
Boehringer IngelheimJardiance, Tradjenta$391$21,26529 claims
PfizerEliquis$356$13,15822 claims
AstraZenecaFarxiga$1,018$12,17016 claims
Astellas Pharma US IncMyrbetriq$923$11,79819 claims
GSKTrelegy Ellipta$570$9,03914 claims
AbbVieSynthroid$332$1,03914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Niceville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →